hMENA11a contributes to HER3-mediated resistance to PI3K inhibitors in HER2-overexpressing breast cancer cells
P. Trono, F. Di Modugno, R. Circo, S. Spada, A. Di Benedetto, R. Melchionna, B. Palermo, S. Matteoni, S. Soddu, M. Mottolese, Ruggero De Maria Marchiano, P. Nisticò
Dive into the research topics of 'hMENA11a contributes to HER3-mediated resistance to PI3K inhibitors in HER2-overexpressing breast cancer cells'. Together they form a unique fingerprint.